Insiders · AMAM

AMAM insider transactions

Ambrx Biopharma Inc. (AMAM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for AMAM

• 822d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  O'Connor Daniel J. returned 48,202 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  Nelson Sonja returned 22,936 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Dalesandro Margaret

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 992d
  SEC Form 4: Cormorant Asset Management, Lp bought $19,625,601 worth of Ordinary Shares (2,152,738 units at $9.12)

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1005d
  SEC Form 4: Dalesandro Margaret was granted 195,833 units of Ordinary Shares

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1005d
  SEC Form 3 filed by new insider Dalesandro Margaret

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by O'Connor Daniel J.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1075d
  SEC Form 4 filed by Darwin Global Management, Ltd.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Chang Xiaowei

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1108d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1115d
  SEC Form 3 filed by new insider Glover Stephen C.

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1129d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1129d
  SEC Form 3 filed by new insider Aromando Andrew

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1136d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1136d
  SEC Form 4 filed by O'Connor Daniel J.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1144d
  SEC Form 4 filed by Cormorant Asset Management, Lp

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1147d
  SEC Form 4 filed by Cormorant Asset Management, Lp

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1179d
  SEC Form 4: Cormorant Asset Management, Lp bought $10,211,400 worth of Ordinary Shares (1,000,000 units at $10.21)

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1182d
  SEC Form 3: New insider Cormorant Asset Management, Lp claimed ownership of 52,500,000 units of Ordinary Shares

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1187d
  SEC Form 4 filed by Darwin Global Management, Ltd.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1187d
  SEC Form 3 filed by new insider Darwin Global Management, Ltd.

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Rupalla Katrin

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1245d
  SEC Form 3: New insider Wuxi Apptec Co., Ltd. claimed ownership of 29,267,687 units of Ordinary Shares

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3: New insider Hopu Reunion Co Ltd claimed ownership of 38,952,409 units of Ordinary Shares

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Rupalla Katrin

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider O'Connor Daniel J.

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Nelson Sonja

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Maier Paul V

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Loesberg Janet

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3: New insider Hu Edward claimed ownership of 1,215,472 units of Ordinary Shares

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Hermans Kate

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1251d
  SEC Form 3 filed by new insider Chang Xiaowei

  3 - Ambrx Biopharma Inc. (0001836056) (Issuer)